Matches in SemOpenAlex for { <https://semopenalex.org/work/W2967053733> ?p ?o ?g. }
- W2967053733 endingPage "1022" @default.
- W2967053733 startingPage "1013" @default.
- W2967053733 abstract "Abstract Aberrant epigenetic reprogramming is known to be a major cause of inefficient somatic cell nuclear transfer (SCNT) in pigs, and use of epigenetic modification agents, such as DNA methyltransferase inhibitors (DNMTis), is a promising approach for enhancing SCNT efficacy. Here, we attempted to find the optimal condition of zebularine (Zb), a DNMTi, treatment on porcine SCNT embryos during in vitro culture (IVC). As results, treatment with 5 nM Zb for 24 hr showed the highest rate of embryo development to blastocyst compared to other groups ( p < .05). Also, the relative intensities of global DNA methylation levels of anti‐5‐methylcytosine in pseudo‐pronuclear (PNC), 2‐cell and 4‐cell stages were significantly lower in the Zb‐treated group ( p < .05), however, changes in methylation levels of centromeric satellite repeat were noted only in PNC and blastocyst stages. In addition, significant positive alterations in the relative expression of genes related to pluripotency ( OCT4 and SOX2 ), histone acetylation ( HAT1 , HDAC1 , HDAC2 , and HDAC3 ) and DNA methylation ( DNMT1 and DNMT3a ) were observed compared to the control ( p < .05). In conclusion, we found that Zb could modify DNA methylation levels in the early stages of porcine SCNT embryos and promote their developmental competence." @default.
- W2967053733 created "2019-08-22" @default.
- W2967053733 creator A5011405782 @default.
- W2967053733 creator A5022027749 @default.
- W2967053733 creator A5023048198 @default.
- W2967053733 creator A5025152012 @default.
- W2967053733 creator A5036429019 @default.
- W2967053733 creator A5063003522 @default.
- W2967053733 creator A5078059318 @default.
- W2967053733 date "2019-06-05" @default.
- W2967053733 modified "2023-10-16" @default.
- W2967053733 title "Enhancement of epigenetic reprogramming status of porcine cloned embryos with zebularine, a DNA methyltransferase inhibitor" @default.
- W2967053733 cites W105272822 @default.
- W2967053733 cites W1441454452 @default.
- W2967053733 cites W159486472 @default.
- W2967053733 cites W1633663754 @default.
- W2967053733 cites W1966990812 @default.
- W2967053733 cites W1969292432 @default.
- W2967053733 cites W1969367571 @default.
- W2967053733 cites W1976626368 @default.
- W2967053733 cites W1981088384 @default.
- W2967053733 cites W1981186364 @default.
- W2967053733 cites W1985737700 @default.
- W2967053733 cites W1987557775 @default.
- W2967053733 cites W1991512401 @default.
- W2967053733 cites W1992525863 @default.
- W2967053733 cites W1992964809 @default.
- W2967053733 cites W1996431759 @default.
- W2967053733 cites W2010608530 @default.
- W2967053733 cites W2012206386 @default.
- W2967053733 cites W2022550243 @default.
- W2967053733 cites W2022838964 @default.
- W2967053733 cites W2025960524 @default.
- W2967053733 cites W2027117363 @default.
- W2967053733 cites W2043311354 @default.
- W2967053733 cites W2053081056 @default.
- W2967053733 cites W2057713397 @default.
- W2967053733 cites W2060049869 @default.
- W2967053733 cites W2060446375 @default.
- W2967053733 cites W2061578142 @default.
- W2967053733 cites W2067027372 @default.
- W2967053733 cites W2071953998 @default.
- W2967053733 cites W2081195534 @default.
- W2967053733 cites W2092293354 @default.
- W2967053733 cites W2096398203 @default.
- W2967053733 cites W2096942972 @default.
- W2967053733 cites W2097469948 @default.
- W2967053733 cites W2099166288 @default.
- W2967053733 cites W2106844301 @default.
- W2967053733 cites W2107257929 @default.
- W2967053733 cites W2111041465 @default.
- W2967053733 cites W2132375630 @default.
- W2967053733 cites W2135437517 @default.
- W2967053733 cites W2148033621 @default.
- W2967053733 cites W2152752397 @default.
- W2967053733 cites W2163271530 @default.
- W2967053733 cites W2511423471 @default.
- W2967053733 cites W2574762612 @default.
- W2967053733 cites W2591639749 @default.
- W2967053733 cites W2795500674 @default.
- W2967053733 cites W2891563813 @default.
- W2967053733 cites W2905825237 @default.
- W2967053733 cites W2911971804 @default.
- W2967053733 doi "https://doi.org/10.1002/mrd.23178" @default.
- W2967053733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31166644" @default.
- W2967053733 hasPublicationYear "2019" @default.
- W2967053733 type Work @default.
- W2967053733 sameAs 2967053733 @default.
- W2967053733 citedByCount "8" @default.
- W2967053733 countsByYear W29670537332020 @default.
- W2967053733 countsByYear W29670537332021 @default.
- W2967053733 countsByYear W29670537332022 @default.
- W2967053733 crossrefType "journal-article" @default.
- W2967053733 hasAuthorship W2967053733A5011405782 @default.
- W2967053733 hasAuthorship W2967053733A5022027749 @default.
- W2967053733 hasAuthorship W2967053733A5023048198 @default.
- W2967053733 hasAuthorship W2967053733A5025152012 @default.
- W2967053733 hasAuthorship W2967053733A5036429019 @default.
- W2967053733 hasAuthorship W2967053733A5063003522 @default.
- W2967053733 hasAuthorship W2967053733A5078059318 @default.
- W2967053733 hasConcept C104317684 @default.
- W2967053733 hasConcept C1491633281 @default.
- W2967053733 hasConcept C150194340 @default.
- W2967053733 hasConcept C153911025 @default.
- W2967053733 hasConcept C16685009 @default.
- W2967053733 hasConcept C175211621 @default.
- W2967053733 hasConcept C190727270 @default.
- W2967053733 hasConcept C196843134 @default.
- W2967053733 hasConcept C202438428 @default.
- W2967053733 hasConcept C2778177303 @default.
- W2967053733 hasConcept C2779979206 @default.
- W2967053733 hasConcept C33288867 @default.
- W2967053733 hasConcept C41091548 @default.
- W2967053733 hasConcept C54355233 @default.
- W2967053733 hasConcept C552990157 @default.
- W2967053733 hasConcept C71924100 @default.
- W2967053733 hasConcept C77255625 @default.
- W2967053733 hasConcept C86803240 @default.